gland pharma glp-1 manufacturing india emerging as a key backend and hub for obesity drugs. players positioned across brands, APIs, peptides & CDMO value chain. Long-term opportunity driven by global obesity and diabetes The Indian pharmaceutical industry has
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




















